Search results for "Cardiology"

showing 10 items of 6064 documents

Incidence and severity of postthrombotic syndrome after iliofemoral thrombosis - results of the Iliaca-PTS - Registry.

2021

Summary: Background: Deep venous thrombosis (DVT) and in particular, iliofemoral thrombosis (IFT) can lead to recurrent thrombosis and postthrombotic syndrome (PTS). Data on the prevalence, predictors and outcome of IFT are scarce. Patients and methods: We retrospectively searched our database of outpatients who had presented with DVT and IFT including the iliac veins from 2014 until 2017. In addition, we performed a prospective registry in a subgroup of patients with IFT. These patients received duplex ultrasound, magnetic resonance venography and measurement of symptom-free walking distance using a standardized treadmill ergometry. The severity of PTS was analyzed using the Villalta-Scal…

AdultMalemedicine.medical_specialtyAdolescent030204 cardiovascular system & hematologyIliac Vein030218 nuclear medicine & medical imagingPostthrombotic Syndrome03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansRecurrent thrombosisRegistriesAgedRetrospective StudiesAged 80 and overVenous ThrombosisUltrasonography Doppler Duplexbusiness.industryIncidence (epidemiology)Postthrombotic syndromeIncidencePhlebographyMiddle Agedmedicine.diseaseThrombosisMagnetic Resonance ImagingVenous thrombosisTreatment OutcomeCardiologyQuality of LifeFemalesense organsCardiology and Cardiovascular MedicinebusinessVASA. Zeitschrift fur Gefasskrankheiten
researchProduct

Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-media…

2011

Dalcetrapib increases high-density lipoprotein cholesterol (HDL-C) levels through effects on cholesteryl ester transfer protein (CETP). As part of the dalcetrapib dal-HEART clinical trial programme, the efficacy and safety of dalcetrapib is assessed in coronary heart disease (CHD) patients in the dal-VESSEL study (ClinicalTrials.gov identifier: NCT00655538), the design and methods of which are presented here. RESEARCH DESIGN AND STUDY METHOD: Men and women with CHD or CHD risk equivalent, with HDL-C levels50  mg/dL were recruited for a 36-week, double-blinded, placebo-controlled trial. After a pre-randomisation phase of up to 8 weeks, patients received dalcetrapib 600  mg/day or placebo in …

AdultMalemedicine.medical_specialtyAdolescentBrachial ArteryDalcetrapibCoronary DiseaseAtherosclerosis CETP inhibition Endothelial function Flow-mediated dilatation ester transfer protein density-lipoprotein cholesterol off-target toxicity cardiovascular-disease dependent vasodilation coronary risk nitric-oxide torcetrapib atherosclerosis cetpModels BiologicalPlaceboschemistry.chemical_compoundYoung AdultDouble-Blind Methodmedicine.arteryInternal medicineCholesterylester transfer proteinmedicineHumansSulfhydryl CompoundsBrachial arteryLipoprotein cholesterolFlow mediated vasodilatationAgedRationalizationbiologybusiness.industryAnticholesteremic AgentsEstersGeneral MedicineCetp inhibitionMiddle AgedAmidesCoronary heart diseaseClinical trialVasodilationTreatment OutcomechemistryRegional Blood FlowResearch DesignCardiologybiology.proteinlipids (amino acids peptides and proteins)FemaleEndothelium VascularbusinessAlgorithms
researchProduct

Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily

2021

Abstract Background and aims Diabetes mellitus (DM) has been associated with higher incidence of severe cases of COVID-19 in hospitalized patients, but it is unknown whether DM is a risk factor for the overall COVID-19 incidence. The aim of present study was to investigate whether there is an association of DM with COVID-19 prevalence and case fatality, and between different DM medications and risk for COVID-19 infection and death. Methods and results retrospective observational study on all SARS-CoV-2 positive (SARS-CoV-2+) cases and deaths in Sicily up to 2020, May 14th. No difference in COVID-19 prevalence was found between people with and without DM (RR 0.92 [0.79–1.09]). Case fatality …

AdultMalemedicine.medical_specialtyAdolescentCoronavirus disease 2019 (COVID-19)Endocrinology Diabetes and MetabolismMedicine (miscellaneous)030209 endocrinology & metabolism030204 cardiovascular system & hematologySettore MED/13 - EndocrinologiaYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusDiabetes mellitus.Case fatality rateDiabetes MellitusPrevalencemedicineHumansHypoglycemic AgentsRisk factorYoung adultChildSicilyAgedRetrospective StudiesAged 80 and overNutrition and DieteticsSARS-CoV-2business.industryIncidenceIncidence (epidemiology)COVID-19InfantRetrospective cohort studyMiddle Agedmedicine.diseaseEl NiñoCOVID-19 case fatalityChild PreschoolCOVID-19 incidenceFemaleCardiology and Cardiovascular MedicinebusinessNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Inflammatory Bowel Disease as a Precondition for Stroke or TIA: A Matter of Crohn's Disease Rather than Ulcerative Colitis.

2020

Abstract Background As a chronic systemic inflammation may be associated with an increased risk of vascular events, the aim of the present study was to assess the incidence of stroke and transient ischemic attack (TIA) in patients with inflammatory bowel disease over a period of 15 years. Methods This cohort study included patients for whom the initial diagnosis of an inflammatory bowel disease (IBD) (Crohn's disease: CD and ulcerative colitis: UC) was documented anonymously between 2000 and 2015 in 1,262 general practices in Germany. IBD patients were matched to patients without IBD using propensity scores based on age, sex, physician, co-diagnoses and co-therapies. Cox regression models w…

AdultMalemedicine.medical_specialtyAdolescentDatabases FactualDiseaseInflammatory bowel diseaseRisk Assessment03 medical and health sciencesYoung Adult0302 clinical medicineCrohn DiseaseRisk FactorsInternal medicineGermanymedicineHumanscardiovascular diseasesStrokeRetrospective StudiesCrohn's diseaseProportional hazards modelbusiness.industryIncidence (epidemiology)IncidenceRehabilitationMiddle Agedmedicine.diseaseUlcerative colitisStrokeIschemic Attack TransientSurgeryColitis UlcerativeFemaleNeurology (clinical)Cardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryCohort studyJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct

Should we look for silent pulmonary embolism in patients with deep venous thrombosis?

2014

Background Asymptomatic or silent pulmonary embolism (S-PE) in patients with deep vein thrombosis has been the focus of numerous publications with the objective of determining the incidence of S-PE and assessing whether its existence has any clinical or therapeutic consequences that outweigh the risks associated with the diagnostic tests performed and the increased healthcare costs. The objectives were to assess the incidence of S-PE using computed tomography angiogram (CTA), to understand the epidemiological factors that might trigger embolism, and to assess whether D-dimer (DD) predicts the existence of S-PE’s. Methods A prospective and consecutive assessment of 103 hospitalized patients …

AdultMalemedicine.medical_specialtyAdolescentDeep veinAsymptomaticFibrin Fibrinogen Degradation ProductsYoung AdultDeep vein thrombosisHumansMedicineProspective StudiesProspective cohort studyAgedAngiologyAged 80 and overVenous Thrombosisbusiness.industryIncidencePulmonary embolismMiddle Agedmedicine.diseaseThrombosisPulmonary embolismRadiographyVenous thrombosismedicine.anatomical_structureEmbolismD-dimerAsymptomatic DiseasesFemaleRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesResearch ArticleBMC Cardiovascular Disorders
researchProduct

Blood pressure for outcome prediction and risk stratification in acute pulmonary embolism.

2015

Abstract Introduction Risk stratification of patients with acute pulmonary embolism (PE) is crucial in deciding appropriate therapy management. Blood pressure (BP) is rapidly available and a reliable parameter. We aimed to investigate BP for short-term outcome in acute PE. Materials and methods Data of 182 patients with acute PE were analyzed retrospectively. Logistic regression models were calculated to investigate associations between BP and in-hospital-death as well as myocardial necrosis. Moreover, receiver operating characteristic (ROC) curves and cutoff values for systolic and diastolic BPs predicting in-hospital death and myocardial necrosis were computed. Results A total of 182 pati…

AdultMalemedicine.medical_specialtyAdolescentDiastoleBlood PressureRisk AssessmentNecrosisYoung AdultInternal medicinemedicineHumansHospital MortalityAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testReceiver operating characteristicbusiness.industryVentilation/perfusion scanMyocardiumArea under the curveBlood Pressure DeterminationGeneral MedicineOdds ratioMiddle Agedmedicine.diseasePrognosisConfidence intervalSurgeryPulmonary embolismBlood pressureLogistic ModelsROC CurveAcute DiseaseEmergency MedicineCardiologyFemalebusinessPulmonary EmbolismThe American journal of emergency medicine
researchProduct

Evaluation of diastolic function by the Tissue doppler in children affected by non- compaction

2007

The Tissue doppler analysis is a new echocardiographic approach to evaluate the diastolic function. In this report we performed a Tissue doppler analysis in a series of 15 children affected by non-compaction. The bidimensional echo-cardiogram showed a systolic function which was reduced only in 8 patients. Alterations of the diastolic function were founded in 7 patients: in 2 cases, a reduction of the E tissue wave was present in all segments. In 3 patients the diastolic dysfunction was limited to apical and lateral segments. In the last 2 children a reduction of the E wave interested only the apical segments. There was a strong correlation between systolic and diastolic dysfunction: in fac…

AdultMalemedicine.medical_specialtyAdolescentDiastoleSystolic functionDoppler echocardiographysymbols.namesakeDiastoleInternal medicineVentricular DysfunctionmedicineHumansDiastolic functionChildmedicine.diagnostic_testbusiness.industryInfantAnatomyEchocardiography DopplerPulse pressureChild PreschoolsymbolsCardiologyFemaleCardiology and Cardiovascular MedicinebusinessDoppler effectTissue doppler analysis Non-compaction Ventricular dysfunction Children
researchProduct

Rosiglitazone Causes Endothelial Dysfunction in Humans

2011

We explored the impact of rosiglitazone on endothelial function in normal volunteers and its interaction with glyceryl trinitrate (GTN)-induced abnormalities in endothelial function. We hypothesized that rosiglitazone would have a neutral effect on endothelial function in normal volunteers and would favorably modify endothelial dysfunction induced by GTN.In this double-blind, randomized, placebo-controlled study, 44 participants were randomized to placebo, rosiglitazone (4 mg twice daily), transdermal GTN (0.6 mg/h), or both GTN and rosiglitazone. After 7 days of treatment, participants underwent measures of forearm blood flow during brachial artery infusion of acetylcholine (Ach). Serum gl…

AdultMalemedicine.medical_specialtyAdolescentEndotheliumVasodilator AgentsBlood PressureVasodilationAscorbic AcidPharmacologyPlaceboRosiglitazoneNitroglycerinYoung AdultDouble-Blind MethodHeart RateInternal medicinemedicine.arterymedicineHumansPharmacology (medical)Endothelial dysfunctionBrachial arteryPharmacologyDose-Response Relationship Drugbusiness.industrymedicine.diseaseAscorbic acidAcetylcholineVasodilationmedicine.anatomical_structureBlood pressureEndocrinologycardiovascular systemThiazolidinedionesEndothelium VascularCardiology and Cardiovascular MedicineRosiglitazonebusinesscirculatory and respiratory physiologymedicine.drugJournal of Cardiovascular Pharmacology and Therapeutics
researchProduct

Rationale for and design of the CREATIVE-AF trial: randomized, double-blind, placebo-controlled, crossover study of the effect of irbesartan on oxida…

2008

Background and objective: Atrial fibrillation (AF) is the most common cardiac arrhythmia. Recent studies suggest there is an angiotensin II-dependent increase in adhesion molecules and oxidative stress parameters during AF. These alterations appear to contribute to inflammatory and prothrombotic changes in the atrial endocardium (‘endocardial remodelling’), suggesting that patients with increased levels of these factors might be at risk of thromboembolic events. The purpose of the CREATIVE-AF (Impact of Irbesartan on Oxidative Stress and C-Reactive Protein Levels in Patients with Persistent Atrial Fibrillation) trial is to prove the principle concept that blockade of angiotensin II type 1 r…

AdultMalemedicine.medical_specialtyAdolescentEndpoint DeterminationTetrazolesmedicine.disease_causeYoung AdultIrbesartanVon Willebrand factorDouble-Blind MethodInternal medicineAtrial FibrillationmedicineHumansPharmacology (medical)Cell adhesionAgedCross-Over StudiesbiologyCell adhesion moleculebusiness.industryPatient SelectionBiphenyl CompoundsAtrial fibrillationGeneral MedicineIrbesartanMiddle Agedmedicine.diseaseAngiotensin IICrossover studyOxidative StressData Interpretation StatisticalSample SizeCardiologybiology.proteinFemalebusinessAngiotensin II Type 1 Receptor BlockersCell Adhesion MoleculesOxidative stressBiomarkersmedicine.drugClinical drug investigation
researchProduct

Insulin resistance and oxidative stress in familial combined hyperlipidemia.

2007

Oxidative stress is associated with atherosclerosis. Familial combined hyperlipidemia (FCH) is considered as a human model of primary dyslipidemia and atherosclerosis frequently associated with insulin resistance (IR), but there are few data on its possible relation to oxidative stress. The objective of this study was to evaluate oxidative stress status using different markers in subjects with FCH assessing its possible correlation with anthropometric parameters and IR. This was a cross-sectional study. A cohort of 40 FCH patients (20 with IR (HOMAor=3.2) and 20 without IR (HOMA3.2)), and 20 healthy volunteers were included, all of them non-diabetic, normotensive and non-smokers. We measure…

AdultMalemedicine.medical_specialtyAdolescentHyperlipidemia Familial Combinedmedicine.disease_causeAnthropometric parametersInsulin resistanceInternal medicinemedicineHumansAgedGlutathione Disulfidebusiness.industryVascular diseasenutritional and metabolic diseasesDeoxyguanosineMiddle Agedmedicine.diseaseAtherosclerosisGlutathioneLipidsFamilial combined hyperlipidemiaOxidative StressEndocrinology8-Hydroxy-2'-DeoxyguanosineCohortFemaleInsulin ResistanceCardiology and Cardiovascular MedicinebusinessDyslipidemiaOxidative stressAtherosclerosis
researchProduct